DDI2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.625200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.324200E-01
Normal-vs-Stage2
7.966200E-01
Normal-vs-Stage3
2.364600E-01
Normal-vs-Stage4
2.804600E-01
Stage1-vs-Stage2
8.259600E-01
Stage1-vs-Stage3
2.776400E-01
Stage1-vs-Stage4
1.665780E-01
Stage2-vs-Stage3
3.271800E-01
Stage2-vs-Stage4
3.988300E-02
Stage3-vs-Stage4
2.621900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.358600E-01
Normal-vs-AfricanAmerican
5.659600E-01
Normal-vs-Asian
2.758400E-01
Caucasian-vs-AfricanAmerican
8.391800E-02
Caucasian-vs-Asian
2.159400E-01
AfricanAmerican-vs-Asian
4.256500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.516600E-01
Normal-vs-Female
8.812800E-01
Male-vs-Female
3.717400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.319200E-01
Normal-vs-Age(41-60Yrs)
8.728600E-01
Normal-vs-Age(61-80Yrs)
6.022400E-01
Normal-vs-Age(81-100Yrs)
3.627000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.699400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.403400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.666200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.281900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.163800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.348600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.486600E-01
Normal-vs-Daily Drinker
3.066400E-01
Normal-vs-Weekly Drinker
4.440200E-01
Normal-vs-Occasional Drinker
8.492200E-01
Normal-vs-Social Drinker
9.969600E-01
Non Drinker-vs-Daily Drinker
8.700200E-01
Non Drinker-vs-Weekly Drinker
8.942800E-01
Non Drinker-vs-Occasional Drinker
5.477600E-02
Non Drinker-vs-Social Drinker
1.781600E-01
Daily Drinker-vs-Weekly Drinker
8.192400E-01
Daily Drinker-vs-Occasional Drinker
4.425900E-02
Daily Drinker-vs-Social Drinker
1.300650E-01
Weekly Drinker-vs-Occasional Drinker
1.340820E-01
Weekly Drinker-vs-Social Drinker
2.745800E-01
Occasional Drinker-vs-Social Drinker
7.481000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.288200E-01
Normal-vs-Grade 2
2.069400E-01
Normal-vs-Grade 3
1.060590E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.544200E-01
Grade 1-vs-Grade 3
3.912200E-01
Grade 1-vs-Grade 4
3.288200E-01
Grade 2-vs-Grade 3
5.681200E-01
Grade 2-vs-Grade 4
2.069400E-01
Grade 3-vs-Grade 4
1.060590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.638400E-01
Normal-vs-NonDiabetic
5.813200E-01
Diabetic-vs-NonDiabetic
7.690000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.508600E-01
Normal-vs-NoPancreatitis
6.432200E-01
Pancreatitis-vs-NoPancreatitis
6.914400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.256200E-01
Normal-vs-N1
8.389200E-01
N0-vs-N1
3.623200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.903600E-01
Normal-vs-TP53-NonMutant
8.330000E-01
TP53-Mutant-vs-TP53-NonMutant
4.647200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
